Current Edition

‘First’ Therapeutic Approvals Bring Patients Hope

When novel drugs and biologics hit the market, the treatment horizon for many patients is suddenly broadened. US Food and Drug Administration (FDA) ‘firsts’ can present a vital step toward advancing the health of patients. Deborah Komlos at Clarivate explores how these ‘first’ therapeutic approvals bring patients hope during difficult times.